Huntsman Answers Urgent Calls for Help in the Fight Against Coronavirus COVID-19
THE WOODLANDS, Texas, March 23, 2020 /PRNewswire/ -- In response to an urgent appeal by Swiss authorities, Huntsman Corporation (NYSE: HUN) today announced it will begin making hydro alcoholic solution to produce hand sanitizer in the Swiss Canton of Vaud and the General Hospital in Lausanne, Switzerland.
At its manufacturing site in Monthey, Switzerland, Huntsman will produce approximately 50 tons of hand sanitizer to donate free of charge to hospitals and pharmacies, which are now facing increasing shortages due to the COVID-19 pandemic and constrained supply of the product.
The first shipment of five tons is expected to be delivered immediately. More production is planned to ensure a stable supply of between three tons and five tons per week as required to help safeguard medical staff, patients and the public.
In recent weeks, Huntsman contributed its chemical products to the fight against the coronavirus COVID-19 in China. The company donated methylene diphenyl diisocyanate (MDI) to enable the manufacture of prefabricated polyurethane insulation panels for hospital construction, and TEROL® polyester polyols, ZEROSTAT® NW and PHOBOL® NW-MD, to manufacture personal protective equipment (PPE) for medical personnel fighting the coronavirus.
"We are very humbled to be in a position to contribute what we do every day to help in the fight against the COVID-19 pandemic," said Peter Huntsman, Chairman, President and CEO of Huntsman Corporation. "As this virus makes its way to every continent, we will continue to leverage our experience and knowledge in other regions, including the U.S."
Huntsman Corporation is a publicly traded global manufacturer and marketer of differentiated and specialty chemicals with 2019 revenues of approximately $7 billion. Our chemical products number in the thousands and are sold worldwide to manufacturers serving a broad and diverse range of consumer and industrial end markets. We operate more than 70 manufacturing, R&D and operations facilities in approximately 30 countries and employ approximately 9,000 associates within our four distinct business divisions. For more information about Huntsman, please visit the company's website at www.huntsman.com.
Certain information in this release constitutes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These statements are based on management's current beliefs and expectations. The forward-looking statements in this release are subject to uncertainty and changes in circumstances and involve risks and uncertainties that may affect the company's operations, markets, products, services, prices and other factors as discussed under the caption "Risk Factors" in the Huntsman companies' filings with the U.S. Securities and Exchange Commission. Significant risks and uncertainties may relate to, but are not limited to, volatile global economic conditions, cyclical and volatile product markets, disruptions in production at manufacturing facilities, reorganization or restructuring of Huntsman's operations, including any delay of, or other negative developments affecting the ability to implement cost reductions, timing of proposed transactions, and manufacturing optimization improvements in Huntsman businesses and realize anticipated cost savings, and other financial, economic, competitive, environmental, political, legal, regulatory and technological factors. The company assumes no obligation to provide revisions to any forward-looking statements should circumstances change, except as otherwise required by applicable laws.
View original content to download multimedia:http://www.prnewswire.com/news-releases/huntsman-answers-urgent-calls-for-help-in-the-fight-against-coronavirus-covid-19-301028368.html
SOURCE Huntsman Corporation
Released March 23, 2020